These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 1093675)
21. In situ expression of soluble B7-1 in the context of oncolytic herpes simplex virus induces potent antitumor immunity. Todo T; Martuza RL; Dallman MJ; Rabkin SD Cancer Res; 2001 Jan; 61(1):153-61. PubMed ID: 11196154 [TBL] [Abstract][Full Text] [Related]
22. Some characteristics of the cyclophosphamide-induced immunopotentiating cells in the spleen of mice bearing a large MOPC-315 tumor. Mokyr MB; Ye QW Cancer Res; 1985 Oct; 45(10):4932-9. PubMed ID: 4027979 [TBL] [Abstract][Full Text] [Related]
23. Quantitation of human tumor-reactive monoclonal antibody 16.88 in the circulation and localization of 16.88 in colorectal metastatic tumor tissue using murine antiidiotypic antibodies. Taddei-Peters WC; Haspel MV; Vente P; Murray JL; Cleary KR; Levin B; Paris EM; Pomato N; Murray JH; Weidman D Cancer Res; 1992 May; 52(9):2603-9. PubMed ID: 1568227 [TBL] [Abstract][Full Text] [Related]
24. A murine model for antibody-directed targeting of vascular endothelial cells in solid tumors. Burrows FJ; Watanabe Y; Thorpe PE Cancer Res; 1992 Nov; 52(21):5954-62. PubMed ID: 1394221 [TBL] [Abstract][Full Text] [Related]
25. Microdistribution of specific rat monoclonal antibodies to mouse tissues and human tumor xenografts. Kennel SJ; Falcioni R; Wesley JW Cancer Res; 1991 Mar; 51(5):1529-36. PubMed ID: 1997194 [TBL] [Abstract][Full Text] [Related]
26. Chimeric (mouse/human) anti-colon cancer antibody c30.6 inhibits the growth of human colorectal cancer xenografts in scid/scid mice. Mount PF; Sutton VR; Li W; Burgess J; McKEnzie IF; Pietersz GA; Trapani JA Cancer Res; 1994 Dec; 54(23):6160-6. PubMed ID: 7954462 [TBL] [Abstract][Full Text] [Related]
29. Host reactivity against clonable tumor cells and the total tumor cell population, studied in a syngeneic murine lymphoma system. Gjedde SB Acta Pathol Microbiol Immunol Scand C; 1983 Apr; 91(2):101-8. PubMed ID: 6349250 [TBL] [Abstract][Full Text] [Related]
30. In vivo acquisition of Fc gamma RII expression on polyoma virus-transformed cells derived from tumors of long latency. Ran M; Katz B; Kimchi N; Halachmi E; Teillaud JL; Even J; Berko-Flint Y; Atlas E; Fridman WH; Witz IP Cancer Res; 1991 Jan; 51(2):612-8. PubMed ID: 1845956 [TBL] [Abstract][Full Text] [Related]
31. Induction of tumor-specific antitumor immunity after chemotherapy with cisplatin in mice bearing MOPC-104E plasmacytoma by modulation of MHC expression on tumor surface. Nio Y; Hirahara N; Minari Y; Iguchi C; Yamasawa K; Toga T; Tamura K Anticancer Res; 2000; 20(5A):3293-9. PubMed ID: 11062756 [TBL] [Abstract][Full Text] [Related]
32. Monoclonal antibodies to a glycolipid antigen on human neuroblastoma cells. Cheung NK; Saarinen UM; Neely JE; Landmeier B; Donovan D; Coccia PF Cancer Res; 1985 Jun; 45(6):2642-9. PubMed ID: 2580625 [TBL] [Abstract][Full Text] [Related]
33. Therapy with unlabeled and 131I-labeled pan-B-cell monoclonal antibodies in nude mice bearing Raji Burkitt's lymphoma xenografts. Buchsbaum DJ; Wahl RL; Normolle DP; Kaminski MS Cancer Res; 1992 Dec; 52(23):6476-81. PubMed ID: 1423295 [TBL] [Abstract][Full Text] [Related]
34. The in vivo depletion of V beta 17a+ T cells results in the inhibition of reticulum cell sarcoma growth in SJL/J mice. Evidence for the use of anticlonotypic antibody therapy in the control of malignancy. Katz JD; Lebow LT; Bonavida B J Immunol; 1989 Aug; 143(4):1387-95. PubMed ID: 2663994 [TBL] [Abstract][Full Text] [Related]
35. Production and characterization of two human glioma xenograft-localizing monoclonal antibodies. Wikstrand CJ; McLendon RE; Bullard DE; Fredman P; Svennerholm L; Bigner DD Cancer Res; 1986 Nov; 46(11):5933-40. PubMed ID: 3756930 [TBL] [Abstract][Full Text] [Related]
36. The specific cytotoxic effects of daunomycin conjugated to antitumor antibodies. Levy R; Hurwitz E; Maron R; Arnon R; Sela M Cancer Res; 1975 May; 35(5):1182-6. PubMed ID: 164280 [TBL] [Abstract][Full Text] [Related]
37. Analysis of surface proteins of mouse lung carcinomas using monoclonal antibodies. Kennel SJ; Foote LJ; Lankford PK Cancer Res; 1981 Sep; 41(9 Pt 1):3465-70. PubMed ID: 6167348 [TBL] [Abstract][Full Text] [Related]
38. Targeting of ganglioside GD2 monoclonal antibody to neuroblastoma. Cheung NK; Neely JE; Landmeier B; Nelson D; Miraldi F J Nucl Med; 1987 Oct; 28(10):1577-83. PubMed ID: 3655911 [TBL] [Abstract][Full Text] [Related]
39. Regulation of cell-mediated immunologic reactivity to Moloney Murine sarcoma virus-induced tumors. III. Further characterization of tumor-specific serum blocking factors. Halliday WJ; Koppi TA; McKenzie IF J Natl Cancer Inst; 1982 Oct; 69(4):939-44. PubMed ID: 6750199 [TBL] [Abstract][Full Text] [Related]
40. Development of resistance to MOPC-315 plasmacytoma after intralesional and intraperitoneal melphalan therapy of tumor-bearing BALB/c mice. I. Enhancement of in vivo rejection responses by combined chemotherapy-immunotherapy. Adler A; Altbaum I J Natl Cancer Inst; 1982 Jun; 68(6):963-9. PubMed ID: 6953275 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]